This activity will be jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Harborside Medical Education.
Continuing Education Credit
To be eligible for documentation of credit, participants must attend the full activity and submit a completed evaluation form. Participants must complete the evaluation online by December 31, 2022.
Upon completion of this activity, participants should be better able to:
- Evaluate treatment paradigms for select solid tumors and hematologic malignancies, based on guidelines and best practices
- Interpret the potential clinical significance of emerging data relevant to safe and effective cancer treatment
- Anticipate and mitigate adverse events (AEs) associated with cancer treatments
- Develop collaborative strategies to enhance communication with, and the quality of life of, individuals undergoing cancer treatment
The intended audience for this live conference is nurse practitioners, physician assistants, clinical nurse specialists, advanced degree nurses, hematology/oncology nurses, pharmacists, and clinicians who specialize in the field of oncology.
It is the policy of the Annenberg Center for Health Sciences at Eisenhower (Annenberg Center) to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All individuals with the potential to impact the content of an accredited education activity are expected to identify and reference off-label product use and disclose relevant financial relationships with ACCME-defined ineligible companies.
The Annenberg Center for Health Sciences assesses relevant financial relationships with its instructors, planners, managers, and other individuals who are in a position to control the content of CE activities. All relevant relationships that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.